


Longevity
Cardio + cognitionThe evidence base most supplements wish they had. 2 g daily of EPA+DHA moves triglycerides, shifts inflammation, and shows up on the cardiovascular endpoints that actually matter.
Subscribe & Save
Easy to cancel anytime
$30/mo
One Time Purchase
Perfect for a test run
$34
EPA and DHA shift membrane fatty-acid composition and downregulate pro-inflammatory eicosanoids. At 2 g/day, trials show 20-30% triglyceride reduction in elevated baseline; REDUCE-IT showed a 25% relative risk reduction in cardiovascular events at higher EPA doses in high-risk subjects. The Omega-3 index (RBC EPA+DHA) is the right marker - serum is noise.
DirectionsTake two softgels with food. Daily use supports steady blood levels.
These statements have not been evaluated by the FDA.
This product is not intended to diagnose, treat, cure, or prevent disease.
Fit check
Using it well
Third-party tested where applicable. Every regulated Rx clears licensed provider review under state rules - no exceptions.
Most protocols perform better when the baseline is measured before you start. Add ApoB, HbA1c, fasting insulin, and the hormones that matter for your goal.
See lab packagesGenerative engine summary
Where we ship
Omega-3 (EPA/DHA) ships anywhere in the United States. Any Rx layer you add later is gated by your state's rules.
Related Guides
6 min read
Zone 2 is not social-media folklore. It is a sustainable aerobic intensity that improves mitochondrial density, insulin sensitivity, and rec...
6 min read
Omega-3 supplementation advice is usually vague. The omega-3 index gives a measurable target and clearer dosing logic than generic fish-oil ...
Related Glossary
Questions
Potency, purity, and triglyceride-form stability. Grocery fish oil often lists total fish oil (not EPA/DHA) and ships with oxidation levels that make the supplement pro-inflammatory. Ours is IFOS-tested every batch.
Both. EPA does the cardiovascular and mood work, DHA does the brain and retinal work. A balanced 2 g/day hits most endpoints; high-EPA mono-products are the exception for specific cases.
If labs flag elevated ApoB or triglycerides, yes - the Omega-3 index tells you whether dose is doing its job. Retest at 12 weeks.
Yes, no interaction. Many members run omega-3 with tirzepatide or semaglutide as part of the foundational stack.